Leadership Overview
Fresenius Kabi has 8 executives leading key functions including finance, technology, operations, marketing, and regional leadership.
Driven by innovation, Fresenius Kabi is dedicated to advancing patient care through specialized medicines and technologies for infusion, transfusion, and clinical nutrition, impacting global health outcomes.
Driven by innovation, Fresenius Kabi is dedicated to advancing patient care through specialized medicines and technologies for infusion, transfusion, and clinical nutrition, impacting global health outcomes.
Leadership Roles at Fresenius Kabi
Ahmed Kammoun - Chief Financial Officer
Ahmed Kammoun, the Chief Financial Officer at Fresenius Kabi, directs financial strategy and oversight for the global organization. This leadership position involves managing all fiscal operations, including budgeting, forecasting, and financial reporting, ensuring robust financial health and compliance across all business units. Kammoun's responsibilities extend to optimizing capital allocation and driving financial performance to support Fresenius Kabi's mission of providing essential medicines and technologies. The Chief Financial Officer's role is critical in maintaining investor confidence and facilitating sustainable growth by implementing sound financial policies and controls. This executive ensures that financial resources are effectively deployed to advance the company's strategic objectives in infusion, transfusion, and clinical nutrition. Ahmed Kammoun's financial acumen underpins the company's ability to navigate complex global markets and deliver on its healthcare commitments.
Alex Garini - Executive Vice President & Chief Financial Officer
Alex Garini, the Executive Vice President & Chief Financial Officer at Fresenius Kabi, provides critical financial leadership and strategic fiscal management. This senior role involves overseeing all financial planning, analysis, and reporting functions, ensuring the company's financial stability and driving profitable growth across its global operations in infusion, transfusion, and clinical nutrition. Garini's responsibilities include managing capital structure, optimizing financial performance, and ensuring compliance with all regulatory requirements. The Executive Vice President & Chief Financial Officer's strategic insights are essential for guiding investment decisions and supporting Fresenius Kabi's long-term business objectives. Alex Garini's financial expertise is key to maintaining the company's strong market position and facilitating its mission to improve patient outcomes worldwide.
Christian Mattis - Chief Financial Officer, Medtech NAM
Christian Mattis, the Chief Financial Officer, Medtech NAM at Fresenius Kabi, directs financial operations and strategy for the Medtech division within North America. This role focuses on managing the financial health of the Medtech business, encompassing budgeting, forecasting, and financial reporting specific to the region's operations in infusion, transfusion, and clinical nutrition technologies. Mattis ensures financial discipline and supports strategic decision-making to drive growth and profitability within the North American market. The Chief Financial Officer, Medtech NAM's expertise is vital for optimizing resource allocation and identifying financial opportunities to enhance Fresenius Kabi's market leadership. Christian Mattis's financial stewardship is critical for the sustained success and expansion of the Medtech segment in North America.
Rakesh Patel - Chief Operating Officer
Rakesh Patel, the Chief Operating Officer at Fresenius Kabi, oversees the company's global operational strategies and execution. This executive directs the day-to-day business activities, focusing on optimizing manufacturing processes, supply chain management, and overall operational efficiency to support the delivery of medicines and technologies for infusion, transfusion, and clinical nutrition. Patel's responsibilities include ensuring seamless integration of operations across Fresenius Kabi's worldwide locations, driving productivity, and maintaining the highest standards of quality and safety. The Chief Operating Officer plays a pivotal role in translating strategic goals into tangible operational outcomes, enhancing the company's capacity to serve patients and healthcare providers globally. Rakesh Patel's operational leadership is fundamental to Fresenius Kabi's ability to meet market demands and uphold its reputation for reliability and excellence.
Scott Meacham - President, Pharmaceuticals (USA)
Scott Meacham, the President, Pharmaceuticals (USA) at Fresenius Kabi, leads the strategic direction and operational execution for the pharmaceutical business within the United States. This executive role involves overseeing all aspects of the pharmaceutical division, including sales, marketing, and product development, to ensure alignment with Fresenius Kabi's global mission in infusion, transfusion, and clinical nutrition. Meacham drives market growth and strengthens the company's position by fostering innovation and ensuring the delivery of high-quality pharmaceutical products to the U.S. market. The President, Pharmaceuticals (USA)'s leadership is crucial for navigating the complexities of the U.S. healthcare landscape and expanding access to essential medicines. Scott Meacham's strategic oversight is fundamental to Fresenius Kabi's success and impact in the United States.
Takaaki Okado - Representative Director and President
Takaaki Okado, the Representative Director and President at Fresenius Kabi, holds ultimate responsibility for the company's strategic vision and global operations. This leadership position involves guiding Fresenius Kabi's overall direction, ensuring its mission to provide essential medicines and technologies for infusion, transfusion, and clinical nutrition is met with excellence worldwide. Okado directs corporate strategy, oversees key business initiatives, and fosters a culture of innovation and quality across all international markets. The Representative Director and President's role is critical in shaping the company's future, driving sustainable growth, and reinforcing its commitment to improving patient care globally. Takaaki Okado's leadership ensures Fresenius Kabi remains a trusted partner in healthcare, delivering vital solutions to meet evolving medical needs.
Vaibhav Pimpale - Chief Technology Officer
Vaibhav Pimpale, the Chief Technology Officer at Fresenius Kabi, architects the company's technological vision and execution. This role involves leading the development and implementation of innovative technology solutions that enhance Fresenius Kabi's product offerings and operational efficiency in infusion, transfusion, and clinical nutrition. Pimpale oversees all aspects of information technology, driving digital transformation initiatives and ensuring the security and scalability of the company's tech infrastructure. The Chief Technology Officer's strategic direction is vital for leveraging cutting-edge advancements to improve patient care and streamline global operations. Vaibhav Pimpale's leadership ensures that Fresenius Kabi remains at the forefront of technological innovation within the healthcare sector, supporting the company's worldwide presence and commitment to quality.
Katherine Luterek - Senior Business Development Manager & Chief Marketing Officer, Sterile Fill Finish
Katherine Luterek, the Senior Business Development Manager & Chief Marketing Officer, Sterile Fill Finish at Fresenius Kabi, drives strategic growth initiatives and market positioning for critical sterile fill finish operations. This dual role encompasses identifying new business opportunities, forging key partnerships, and developing comprehensive marketing strategies to enhance Fresenius Kabi's presence in specialized healthcare segments. Luterek's focus on sterile fill finish operations is crucial for the company's advanced medicines and technologies in infusion and transfusion. The Senior Business Development Manager & Chief Marketing Officer, Sterile Fill Finish's expertise ensures market penetration and revenue growth by aligning business development efforts with targeted marketing campaigns. Katherine Luterek's leadership is instrumental in expanding Fresenius Kabi's market share and solidifying its reputation for excellence in specialized pharmaceutical manufacturing.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership CS
MK
MB
MH
Founded in 1954 and headquartered in Suresnes, France, Servier international is an independent pharmaceutical company governed by a non-profit foundation. Their three research centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in their production centres around the world.
Company Leadership AK
VT
KP
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership
LB
CM
BM
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates. Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates. In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods. Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system. Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 45 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of "building a healthier Indonesia for everyone one person at a time", Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people. DARYA VARIA
Company Leadership CH
Frequently Asked Questions Regarding Fresenius Kabi Top Executives and Leadership Team
Unlock more people and company data
